A Polymer-Triton X-100 Conjugate Capable of PH-Dependent Red Blood Cell Lysis: A Model System Illustrating the Possibility of Drug Delivery Within Acidic Intracellular Compartments
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 2 (4) , 341-347
- https://doi.org/10.3109/10611869409015915
Abstract
Poly(amidoamines) are soluble polymers containing tertiary amino and amido groups regularly arranged along the macromolecular chain, and their net average charge alters considerably as pH changes from neutral to acidic leading to a change in conformation. This property provides the possibility to design polymer-drug conjugates that are, following intravenous administration, relatively compacted and thus protect a drug payload in the circulation, but following pinocytic internalisation into acidic intracellular compartments unfold permitting pH-triggered intracellular drug delivery. To study the feasibility of this approach, a covalent conjugate of a poly(amidoamine) (MBI) was prepared to contain the membrane lytic non-ionic detergent Triton X-100 (as a model), and its ability to lyse red blood cells in vitro was used as an indicator of conjugate conformation at at different pHs. Although Triton X-100 was highly lytic at pH 5.5, 7.4 and 8.0, and the parent polymer MBI was not lytic under any conditions, the conjugate only showed concentration-dependent red blood cell lysis at pH 5.5. Moreover, incubation of human leukaemic cells (CCRF) with these substrates showed conjugate to be more toxic than MBI (IC50 values of 100 micrograms/ml and 650 micrograms/ml respectively) and less toxic than Triton X-100 (IC50 of 1 microgram/ml).Keywords
This publication has 13 references indexed in Scilit:
- Inhibition of leukaemia cell proliferation by folic acid–polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cellsBritish Journal of Cancer, 1994
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Preclinical evaluation of polymer-bound doxorubicinJournal of Controlled Release, 1992
- The therapeutic value of poly(ethylene glycol)-modified proteinsAdvanced Drug Delivery Reviews, 1991
- SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapyAdvanced Drug Delivery Reviews, 1991
- Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicityJournal of Biomaterials Science, Polymer Edition, 1991
- Synthesis, physico-chemical properties and biomedical applications of poly(amidoamine)sPolymer, 1985
- Partially quaternized poly(tertiary amine) as pH-dependent drug carrier for solubilization and temporary trapping of lipophilic drugs in aqueous mediaJournal of Controlled Release, 1985
- Phospholipid-dependent changes in membrane permeability induced by staphylococcal δ-lysin and bee venom melittinCanadian Journal of Biochemistry and Cell Biology, 1985
- Linear amino polymers: Synthesis, protonation and complex formationPublished by Springer Nature ,1984